Because the NLRP3 inflammasome sequelae are critical to the development ofatherosclerosis by orchestrating the expression of inflammatory cytokines, it islikely that direct inhibition of inflammatory pathways through the NLRP3inflammasome would be a promising therapy for atherosclerosis. This evidence concerns the gene NLRP3 and atherosclerosis.